Aprea Therapeutics Inc (APRE) stock forecast · $10.4M cap
Aprea Therapeutics Inc (APRE) is a biotechnology company listed on US.
This APRE forecast page states what the cached financials imply — not a price target and not a guarantee. Aprea Therapeutics Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for APRE yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for APRE, so this page does not invent a growth rate.
APRE currently screens at market cap $10.4M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next APRE 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the APRE stock page.
Not investment advice.